RhoA stimulates p27(Kip) degradation through its regulation of cyclin E/CDK2 activity

W Hu1, C J Bellone, J J Baldassare

  • 1Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri 63110, USA.

Insights

RhoA regulates cell cycle progression by controlling cyclin E/CDK2 activity, which is essential for p27(Kip) degradation. This pathway is key for cell proliferation in fibroblasts.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • RhoA is a key regulator of cell proliferation.
  • The Ras/RhoA pathway influences p27(Kip) degradation and cell cycle progression from G1 to S phase.

Purpose of the Study:

  • To investigate the role of RhoA in regulating cyclin E/CDK2 activity and p27(Kip) degradation in Chinese hamster embryo fibroblasts (IIC9 cells).

Main Methods:

  • Utilized dominant-negative CDK2 and constitutively active RhoA(63) expression in IIC9 cells.
  • Assessed the impact of RhoA and CDK2 manipulation on cyclin E/CDK2 activity and p27(Kip) degradation.
  • Employed cotransfection and rescue experiments with catalytically active cyclin E/CDK2.

Main Results:

  • RhoA regulates cyclin E/CDK2 activity, which is necessary for p27(Kip) degradation.
  • Dominant-negative CDK2 inhibited serum-induced cyclin E/CDK2 activity and p27(Kip) degradation.
  • Constitutively active RhoA(63) stimulated cyclin E/CDK2 activity and p27(Kip) degradation in the absence of serum.
  • Dominant-negative RhoA blocked serum-induced cyclin E/CDK2 activity and p27(Kip) degradation.

Conclusions:

  • RhoA acts upstream of cyclin E/CDK2 to regulate p27(Kip) degradation.
  • The RhoA/cyclin E/CDK2 pathway is a critical mechanism controlling cell cycle progression.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...